Barratt J - Search Results

1

Clinicopathologic Manifestations of Immunoglobulin A Nephropathy in a Northern Indian Cohort: A Mute Assassin with Delayed Diagnosis.

Prasad N, Khurana M, Behera M, Yaccha M, Bhadauria D, Agarwal V, Kushwaha R, Patel M, Kaul A, Barratt J, Jain M. Prasad N, et al. Among authors: barratt j. Indian J Nephrol. 2023 Jan-Feb;33(1):12-21. doi: 10.4103/ijn.ijn_351_21. Epub 2022 Nov 21. Indian J Nephrol. 2023. PMID: 37197052 Free PMC article.

2

An update on corticosteroid treatment for IgA nephropathy.

Ghaddar M, Barratt J, Barbour SJ. Ghaddar M, et al. Among authors: barratt j. Curr Opin Nephrol Hypertens. 2023 May 1;32(3):263-270. doi: 10.1097/MNH.0000000000000881. Epub 2023 Mar 2. Curr Opin Nephrol Hypertens. 2023. PMID: 36866805 Review.

3

Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis.

Vaz de Castro PAS, Amaral AA, Almeida MG, Selvaskandan H, Barratt J, Simões E Silva AC. Vaz de Castro PAS, et al. Among authors: barratt j. J Nephrol. 2024 Mar 1. doi: 10.1007/s40620-023-01874-8. Online ahead of print. J Nephrol. 2024. PMID: 38427309 Review.

4

Treatment of IgA nephropathy.

Barratt J, Feehally J. Barratt J, et al. Kidney Int. 2006 Jun;69(11):1934-8. doi: 10.1038/sj.ki.5000419. Kidney Int. 2006. PMID: 16641928 Free article. Review.

5

Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.

Graham-Brown MP, Singh A, Wormleighton J, Brunskill NJ, McCann GP, Barratt J, Burton JO, Xu G. Graham-Brown MP, et al. Among authors: barratt j. BMC Nephrol. 2019 Jul 11;20(1):256. doi: 10.1186/s12882-019-1447-2. BMC Nephrol. 2019. PMID: 31296183 Free PMC article.

6

IgA nephropathy: an overview of drug treatments in clinical trials.

Selvaskandan H, Gonzalez-Martin G, Barratt J, Cheung CK. Selvaskandan H, et al. Among authors: barratt j. Expert Opin Investig Drugs. 2022 Dec;31(12):1321-1338. doi: 10.1080/13543784.2022.2160315. Epub 2023 Jan 1. Expert Opin Investig Drugs. 2022. PMID: 36588457 Review.

7

New Insights into the Pathogenesis and Treatment Strategies in IgA Nephropathy.

Scionti K, Molyneux K, Selvaskandan H, Barratt J, Cheung CK. Scionti K, et al. Among authors: barratt j. Glomerular Dis. 2021 Oct 1;2(1):15-29. doi: 10.1159/000519973. eCollection 2022 Jan. Glomerular Dis. 2021. PMID: 36751267 Free PMC article. Review.

8

Long-Term Outcomes in IgA Nephropathy.

Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, Steenkamp R, Wong K, Turner AN, Wang K, Gale DP, Barratt J. Pitcher D, et al. Among authors: barratt j. Clin J Am Soc Nephrol. 2023 Jun 1;18(6):727-738. doi: 10.2215/CJN.0000000000000135. Epub 2023 Apr 13. Clin J Am Soc Nephrol. 2023. PMID: 37055195

9

IgA nephropathy in adults-treatment standard.

Gleeson PJ, O'Shaughnessy MM, Barratt J. Gleeson PJ, et al. Among authors: barratt j. Nephrol Dial Transplant. 2023 Oct 31;38(11):2464-2473. doi: 10.1093/ndt/gfad146. Nephrol Dial Transplant. 2023. PMID: 37418237 Free PMC article. Review.

10

Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.

Barratt J, Liew A, Yeo SC, Fernström A, Barbour SJ, Sperati CJ, Villanueva R, Wu MJ, Wang D, Borodovsky A, Badri P, Yureneva E, Bhan I, Cattran D; Cemdisiran Phase 2 Study Investigators and Collaborators. Barratt J, et al. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):452-462. doi: 10.2215/CJN.0000000000000384. Epub 2024 Jan 15. Clin J Am Soc Nephrol. 2024. PMID: 38214599 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

444 results

Search Page